KR960003618B1 - 4-카르바모일-1-β-D-리보푸라노실 이미다졸륨-5-올레이트 무수결정 - Google Patents
4-카르바모일-1-β-D-리보푸라노실 이미다졸륨-5-올레이트 무수결정 Download PDFInfo
- Publication number
- KR960003618B1 KR960003618B1 KR1019900017154A KR900017154A KR960003618B1 KR 960003618 B1 KR960003618 B1 KR 960003618B1 KR 1019900017154 A KR1019900017154 A KR 1019900017154A KR 900017154 A KR900017154 A KR 900017154A KR 960003618 B1 KR960003618 B1 KR 960003618B1
- Authority
- KR
- South Korea
- Prior art keywords
- crystals
- crystal
- anhydrous
- monohydrate
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000013078 crystal Substances 0.000 title claims description 81
- 229940049964 oleate Drugs 0.000 title claims description 5
- 238000000862 absorption spectrum Methods 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 238000010521 absorption reaction Methods 0.000 claims description 9
- 230000002452 interceptive effect Effects 0.000 claims description 3
- 150000004682 monohydrates Chemical class 0.000 description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 238000004140 cleaning Methods 0.000 description 11
- 238000003756 stirring Methods 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical group CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000010287 polarization Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- HZQDCMWJEBCWBR-UUOKFMHZSA-N Mizoribine Chemical compound OC1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 HZQDCMWJEBCWBR-UUOKFMHZSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 229950000844 mizoribine Drugs 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 238000001159 Fisher's combined probability test Methods 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229960004977 anhydrous lactose Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/052—Imidazole radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP89-291078 | 1989-11-10 | ||
| JP1291078A JPH0615556B2 (ja) | 1989-11-10 | 1989-11-10 | 4―カルバモイル―1―β―D―リボフラノシル―イミダゾリウム―5―オレイト無水結晶 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR910009723A KR910009723A (ko) | 1991-06-28 |
| KR960003618B1 true KR960003618B1 (ko) | 1996-03-20 |
Family
ID=17764149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019900017154A Expired - Lifetime KR960003618B1 (ko) | 1989-11-10 | 1990-10-25 | 4-카르바모일-1-β-D-리보푸라노실 이미다졸륨-5-올레이트 무수결정 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5442051A (cg-RX-API-DMAC10.html) |
| EP (1) | EP0428879B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JPH0615556B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR960003618B1 (cg-RX-API-DMAC10.html) |
| AT (1) | ATE135364T1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU631256B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2028416C (cg-RX-API-DMAC10.html) |
| DE (1) | DE69025859T2 (cg-RX-API-DMAC10.html) |
| IE (1) | IE62718B1 (cg-RX-API-DMAC10.html) |
| NZ (1) | NZ235899A (cg-RX-API-DMAC10.html) |
| TW (1) | TW199164B (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4818994B2 (ja) * | 2000-01-26 | 2011-11-16 | 旭化成ファーマ株式会社 | 色調変化の改善されたミゾリビン錠剤 |
| TWI275394B (en) * | 2000-01-26 | 2007-03-11 | Asahi Chemical Corp | Mizoribin tablet improved with color tone change |
| JP2001300293A (ja) * | 2000-04-25 | 2001-10-30 | Nipro Corp | 無機無水物または有機無水物の製造法 |
| CN103450300B (zh) * | 2013-09-12 | 2015-10-28 | 华北制药集团新药研究开发有限责任公司 | 一种咪唑立宾的提纯方法 |
| JPWO2020013330A1 (ja) * | 2018-07-13 | 2021-06-24 | 協和発酵バイオ株式会社 | ユーコミン酸の非溶媒和物結晶及びその製造方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3888843A (en) * | 1973-06-12 | 1975-06-10 | Toyo Jozo Kk | 4-carbamoyl-1-' -d-ribofuranosylimidazolium-5-olate |
| JPS5652038B2 (cg-RX-API-DMAC10.html) * | 1974-03-09 | 1981-12-09 | ||
| JPS511693A (en) * | 1974-06-21 | 1976-01-08 | Toyo Jozo Kk | 44 karubamoiru 11 beetaa dd ribofuranoshiiru imidazoriumu 55 oreitonoseizoho |
| JPS606634B2 (ja) * | 1981-07-16 | 1985-02-19 | キッコーマン株式会社 | サイクリツク−3′,5′−グアニル酸の製造法 |
| IL93164A0 (en) * | 1989-01-24 | 1990-11-05 | Gensia Pharma | Purine nucleosides and their medical use |
| IL99124A (en) * | 1990-08-10 | 1998-02-22 | Gensia Pharma | Substituted imidazole analogs of aica riboside |
-
1989
- 1989-11-10 JP JP1291078A patent/JPH0615556B2/ja not_active Expired - Lifetime
-
1990
- 1990-10-22 TW TW079108909A patent/TW199164B/zh active
- 1990-10-22 DE DE69025859T patent/DE69025859T2/de not_active Expired - Lifetime
- 1990-10-22 AT AT90120255T patent/ATE135364T1/de not_active IP Right Cessation
- 1990-10-22 EP EP90120255A patent/EP0428879B1/en not_active Expired - Lifetime
- 1990-10-23 CA CA002028416A patent/CA2028416C/en not_active Expired - Lifetime
- 1990-10-24 IE IE381790A patent/IE62718B1/en not_active IP Right Cessation
- 1990-10-24 AU AU64939/90A patent/AU631256B2/en not_active Expired
- 1990-10-25 KR KR1019900017154A patent/KR960003618B1/ko not_active Expired - Lifetime
- 1990-10-30 NZ NZ235899A patent/NZ235899A/en unknown
-
1994
- 1994-04-21 US US08/231,011 patent/US5442051A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69025859T2 (de) | 1996-10-31 |
| KR910009723A (ko) | 1991-06-28 |
| NZ235899A (en) | 1991-12-23 |
| IE903817A1 (en) | 1991-05-22 |
| ATE135364T1 (de) | 1996-03-15 |
| JPH03157393A (ja) | 1991-07-05 |
| US5442051A (en) | 1995-08-15 |
| CA2028416A1 (en) | 1991-05-11 |
| DE69025859D1 (de) | 1996-04-18 |
| TW199164B (cg-RX-API-DMAC10.html) | 1993-02-01 |
| CA2028416C (en) | 1999-09-07 |
| AU6493990A (en) | 1991-05-16 |
| JPH0615556B2 (ja) | 1994-03-02 |
| IE62718B1 (en) | 1995-02-22 |
| AU631256B2 (en) | 1992-11-19 |
| EP0428879A3 (en) | 1991-08-07 |
| EP0428879B1 (en) | 1996-03-13 |
| EP0428879A2 (en) | 1991-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI65441C (fi) | Foerfarande foer framstaellning av inklusionskomplex av cyklodextrin och indometacin | |
| US4822807A (en) | Pharmaceutical composition containing a stable modification of torasemide | |
| US5463116A (en) | Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them | |
| HK18496A (en) | Novel crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid (syn isomer) | |
| JPS5953883B2 (ja) | 「はん」痕形成剤 | |
| HK1000798A1 (en) | Gabapentin monohydrate and a process for producing the same | |
| KR880002087B1 (ko) | 항균성 나프티리딘 또는 퀴놀린 화합물의 염 및 그의 제조방법 | |
| DK153948B (da) | Analogifremgangsmaade til fremstilling af vandoploeselige associationsprodukter af (+)-katekin med en aminosyre og eventuelt tillige en anden syre | |
| JP3726291B2 (ja) | 安定な結晶構造を有するベンゾオキサジン化合物およびその製造法 | |
| FI71144B (fi) | Foerfarande foer framstaellning av terapeutiskt aktiv 1-etyl-6-fluor-1,4-dihydro-4-oxo-(1-piperazinyl)-1,8-naftyridin-3-karboxylsyraseskvihydrat | |
| Jolles et al. | The isolation of small quantities of glucosamine and chondrosamine | |
| KR960003618B1 (ko) | 4-카르바모일-1-β-D-리보푸라노실 이미다졸륨-5-올레이트 무수결정 | |
| JPH05125102A (ja) | 市販カラゲニン類の精製方法 | |
| James et al. | 130. The action of alkaline reagents on 2: 3-1: 6-and 3: 4-1: 6-dianhydro β-talose. A constitutional synthesis of chondrosamine and other amino-sugar derivatives | |
| US4631292A (en) | 1,3-dioxane derivatives, method of their synthesis and anti-peptic ulcer agent | |
| US2729642A (en) | Water soluble salts of 8-(para-aminobenzyl) caffeine and method for their preparation | |
| CA2007367C (en) | Process and composition for the purification of amphotericin b | |
| KR19980064288A (ko) | 다형태를 갖는 독사조신 메실레이트의 새로운 형태(제 iii 형) | |
| TWI680983B (zh) | 一種鈉-葡萄糖共同轉運蛋白2抑制劑的l-脯胺酸複合物、其一水合物及晶體 | |
| KR20150042275A (ko) | 3-포르밀리파마이신 sv 및 3-포르밀리파마이신 s의 3-(4-신나밀-l-피페라지닐) 아미노 유도체를 함유하는 제약 제제 및 그의 제조 방법 | |
| EP0101170B1 (en) | Process for the manufacture of sodium cefoperazone | |
| CN1951919A (zh) | 米力农盐的制备方法及其应用 | |
| Parke et al. | The preparation and properties of sodium d-pantothenate | |
| JP4662640B2 (ja) | 5−クロロ−2−メトキシ−n−(2−(4−メトキシ−3−メチルアミノチオカルボニルアミノスルホニルフェニル)エチル)ベンズアミドナトリウム塩の結晶形 | |
| CA2479888A1 (en) | New crystalline forms of (2s)-n-5-¬amino(imino)methyl|-2-thienylmethyl-1-(2r)-2-¬(carboxymethyl)amino|-3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nh2o |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19901025 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19921111 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19901025 Comment text: Patent Application |
|
| G160 | Decision to publish patent application | ||
| PG1605 | Publication of application before grant of patent |
Comment text: Decision on Publication of Application Patent event code: PG16051S01I Patent event date: 19960221 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 19960604 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 19960725 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 19960725 End annual number: 3 Start annual number: 1 |
|
| PR1001 | Payment of annual fee |
Payment date: 19990309 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20000317 Start annual number: 5 End annual number: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20010315 Start annual number: 6 End annual number: 6 |
|
| PR1001 | Payment of annual fee |
Payment date: 20020313 Start annual number: 7 End annual number: 7 |
|
| PR1001 | Payment of annual fee |
Payment date: 20030311 Start annual number: 8 End annual number: 8 |
|
| PR1001 | Payment of annual fee |
Payment date: 20040310 Start annual number: 9 End annual number: 9 |
|
| PR1001 | Payment of annual fee |
Payment date: 20050309 Start annual number: 10 End annual number: 10 |
|
| PR1001 | Payment of annual fee |
Payment date: 20060313 Start annual number: 11 End annual number: 11 |
|
| PR1001 | Payment of annual fee |
Payment date: 20070319 Start annual number: 12 End annual number: 12 |
|
| PR1001 | Payment of annual fee |
Payment date: 20080310 Start annual number: 13 End annual number: 13 |
|
| PR1001 | Payment of annual fee |
Payment date: 20090311 Start annual number: 14 End annual number: 14 |
|
| FPAY | Annual fee payment |
Payment date: 20100310 Year of fee payment: 15 |
|
| PR1001 | Payment of annual fee |
Payment date: 20100310 Start annual number: 15 End annual number: 15 |
|
| EXPY | Expiration of term | ||
| PC1801 | Expiration of term |